Nevro (NVRO) CEO On Chronic Pain Treatments

Nevro (NVRO) is a medical device company that delivers solutions for the treatment of chronic pain. CEO Kevin Thornal joins Oliver Renick to give an overview of the company. NVRO is up over 16% this month. Thornal discusses the latest developments in chronic pain treatments. He then goes over NVRO’s earnings. Its adjusted EPS came in at -$0.65 versus an estimated -$0.77 and revenue came in at $103.86M versus an estimated $96.35M. He also outlines the acquisition of Vyrsa Technologies. Tune in to find out more about the stock market today.